Cormorant Asset Management, LP Connect Biopharma Holdings LTD Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.46 - $5.92 $492,000 - $1.18 Million	-200,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.26 - $23.33 $1.28 Million - $7 Million	-300,000 Reduced 60.0%	200,000 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$18.12 - $28.5 $2.72 Million - $4.28 Million	-150,000 Reduced 23.08%	500,000 $12 Million
Q2 2021 Aug 16, 2021	SELL	$14.16 - $19.53 $4.96 Million - $6.84 Million	-350,000 Reduced 35.0%	650,000 $12.7 Million
Q1 2021 May 17, 2021	BUY	$15.9 - $18.61 $15.9 Million - $18.6 Million	1,000,000 New	1,000,000 $18.5 Million

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $53.9M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.